REPEAT

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7293 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-03-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfunction. Furthermore, the data collection particularly focuses on the experience of the patient and his satisfaction with the treatment. Treatment naive patients as well as pre-treated patients will be included in the study.The maximum observation period per patient is 12 months.Besides the physician's documentation, the patient should fill out a questionnaire at every visit. The questionnaires will be handed out and collected by the physician. Furthermore, an additional questionnaire for the patient's partner can be distributed at each visit in case the partner is willing to participate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Erectile Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Levitra (Vardenafil, BAY38-9456)

Intervention Type DRUG

Patients with diagnosis of erectile dysfunction who get vardenafil in routine treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Levitra (Vardenafil, BAY38-9456)

Patients with diagnosis of erectile dysfunction who get vardenafil in routine treatment

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Outpatients with diagnosis of erectile dysfunction, decision taken by the investigator to prescribe Vardenafil.

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bayer Healthcare AG

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bayer Study Director

Role: STUDY_DIRECTOR

Bayer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Many Locations, , China

Site Status

Many Locations, , Croatia

Site Status

Many Locations, , France

Site Status

Many Locations, , Germany

Site Status

Many Locations, , Hungary

Site Status

Many Locations, , Indonesia

Site Status

Many Locations, , Malaysia

Site Status

Many Locations, , Poland

Site Status

Many Locations, , Saudi Arabia

Site Status

Many Locations, , Singapore

Site Status

Many Locations, , South Africa

Site Status

Many Locations, , South Korea

Site Status

Many Locations, , Spain

Site Status

Many Locations, , Sweden

Site Status

Many Locations, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China Croatia France Germany Hungary Indonesia Malaysia Poland Saudi Arabia Singapore South Africa South Korea Spain Sweden Thailand